clinical trials

Precision-targeted radiation is proving a match for surgery in early-stage lung cancer, offering patients similar long-term survival with less invasiveness, and potentially transforming how this common cancer is treated.

Psoriasis may not have a cure, but significant relief might be found at the dinner table. A clinical trial has shown that the Mediterranean diet could dramatically improve symptoms, quality of life and overall health of those with the condition.

An existing transplant drug has shown promise in slowing the progression of type 1 diabetes in newly diagnosed young people, potentially paving the way for the first therapy that modifies the disease after diagnosis.

A headline-grabbing study on apple cider vinegar has been pulled from the record, striking a blow to the science and wellness worlds. The research, which claimed that the tonic triggered massive weight loss, was found to be riddled with errors.

A study involving more than 1,000 cancer patients has found that a low dose of aspirin halves the risk of colorectal tumors returning after surgery. This readily available and affordable treatment could change the health outcomes of many survivors.

The US Food and Drug Administration (FDA) has approved the first intranasal diuretic for heart, liver and kidney disease patients, aiming to prevent a common and costly issue that results in more than a million hospitalizations each year.

A new drug candidate could become a first-in-class medication, after impressive results in a mid-stage clinical trial for drug-resistant epilepsy. It now moves to Phase 3 trials, raising hope for people who suffer seizures despite being on medication.

In a landmark move, the FDA has given biotech company eGenesis the go-ahead to conduct a wider trial of pig-to-human kidney transplants, marking a significant step forward in addressing the critical organ shortage now facing thousands of Americans.

A new drug that significantly lowers "stubborn" blood pressure is on the horizon, following the results of its Phase III clinical trial. The drug, called baxdrostat, is being hailed as the most promising advance in hypertension management in decades.

This year a clinical trial will test a drug combination designed to bring lasting relief for people with panic disorder – a condition that can upend daily life and be notoriously difficult to treat. No new medications have been approved since 2003.

People with fibromyalgia will soon have access to a new drug that treats the chronic pain condition's most elusive trigger: Poor sleep. Tonmya, a non-opioid under-the-tongue tablet, is the first FDA-approved drug for fibromyalgia in more than 15 years.

A novel drug, evenamide, quieted overactive brain circuits in an animal model of schizophrenia, improving memory, social interaction, and dopamine balance, offering hope for tackling symptoms that current antipsychotics can’t touch.